ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Immunosuppressants >Pimecrolimus

Pimecrolimus

Pimecrolimus Suppliers list
Company Name:BOC Sciences  Gold
Tel:1-631-504-6093
Email:info@bocsci.com
Company Name:Arromax Pharmatech Co., Ltd.  Gold
Tel:0512-62959601 ,15995748448 ; 0512-62954389
Email:meizhang.sales@arromax.com
Company Name:Shanghai Boyle Chemical Co., Ltd.  
Tel:86-21-50180596
Email:sales@boylechem.com
Company Name:J & K SCIENTIFIC LTD.  
Tel:400-666-7788 +86-10-82848833
Email:jkinfo@jkchemical.com;market6@jkchemical.com
Company Name:Chembest Research Laboratories Limited  
Tel:+86(0)21-20908456
Email:sales@biochembest.com; market@biochembest.com
Pimecrolimus Basic information
Topical immunomodulators
Product Name:Pimecrolimus
Synonyms:Picrolimus;ASM 981;Elidel;SDZ-ASM 981;Pimecrolimus;15,19-Epoxy-3H-pyrido(2,1-C)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 3-((1E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26as)-;15,19-Epoxy-3H-pyrido(2,1-C)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 3-(2-(4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3S-(3R*(E(1S*,3S*,4R*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26ar*))-;Unii-7kyv510875
CAS:137071-32-0
MF:C43H68ClNO11
MW:810.459
EINECS:
Product Categories:Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Elidel, SDZ-ASM-981;Inhibitors
Mol File:137071-32-0.mol
Pimecrolimus Structure
Pimecrolimus Chemical Properties
density 1.19
storage temp. -20°C Freezer
Safety Information
MSDS Information
Pimecrolimus Usage And Synthesis
Topical immunomodulatorsPimecrolimus is a topical immunomodulators and is a kind of semi-synthetic products of the Streptomyces-produced ascomycin. It has a greater lipophilicity than tacrolimus with a stronger affinity with the skin. It can effectively and safely control the signs and symptoms of facial seborrheic dermatitis and can quickly relieve the itching symptoms of patients with dermatitis and eczema as well as reduce the lesion area, clear atopic dermatitis (eczema) sign. Therefore, it is an effective treatment method for the treatment of atopic dermatitis (eczema) for both early remission purpose and long-term control purpose.
Seborrheic dermatitis is the body's immune inflammatory response to lipophilic Malassezia. Both the humoral and cellular immunity participate in the sickening process. Pimecrolimus can selectively inhibit the activation of T cell through inhibiting the activity of the calcium-dependent nerve transcription proteins which is indispensible for the activation of T cells and prevent the release of cytokines and pro-inflammatory mediator, and further exhibiting strong anti-inflammatory activity. These results suggest that the mechanism of pimecrolimus for treatment of seborrheic dermatitis comes from its anti-inflammatory effect and immune regulation. Currently there have been no reports regarding on its direct participation of antifungal activity. But in recent years, there have been reports finding that tacrolimus (a kind of immunomodulatory agents with similar chemical structure and mechanisms as pimecrolimus) have some anti-Malassezia activity.
Similar as the tacrolimus, pimecrolimus is a cellular selective inhibitor which is produced and released by the pro-inflammatory cytokine and can combine with macrophilin 12 (FKBP-12) to inhibit of calcium-dependent calcineurin as well as suppress the T-cell activation through blocking the early cytokines transcription of T cells. In particular, a level of nanogram is enough to suppress the synthesis of T cell IL-2 and IFN-γ (Th1 cell origin) factor and can also inhibit the synthesis of IL-4 and IL (Th2 cell-derived). In addition, in vitro experiments, pimecrolimus can also be applied to inhibit the antigen as well as IgE stimulated mast cells’ release of inflammatory cytokines and inflammatory mediators [4, 5]. Clinical data have shown that after topical application, the blood concentration is very low and is usually under the detected value (<0.5 ng / mL). It also has no drug accumulation phenomenon.
The above information is edited by the Chemicalbook of Dai Xiongfeng.
Chemical PropertiesWhite Solid
UsagePimecrolimus is a semi-synthetic, macrocyclic lactone derived from ascomycin by activation of the 32-hydroxy group with a triflate ester, and nucleophilic substitution with chloride under phase transfer conditions to provide the chloro analogue. Pimecrolimus has been targeted for treatment of inflammatory skin disorders. Like all tacrolimus analogues, pimecrolimus binds to receptor protein, FKBP12. The complex then binds to mTOR preventing it from interacting with target proteins. Pimecrolimus is extensively cited in the literature with over 2,000 citations.
UsageMacrolactam ascomycin derivative; inhibits production of pro-inflammatory cytokines by T cells and mast cells. Immunosuppresant
UsagePimecrolimus caused a strong and dose-dependent inhibition of anti-IgE–induced release of histamine from mast cells and basophils (maximally 73% and 82%, respectively, at 500 nmol/L pimecrolimus) and of mast cell tryptase (maximally 75%) and a less pronou
Pimecrolimus Preparation Products And Raw materials
Tag:Pimecrolimus(137071-32-0) Related Product Information
Tacrolimus Triamcinolone acetonide 1-ACETYL-2-PIPERIDINECARBOXYLIC ACID N,N-DI-N-PROPYL-L-ALANINE 2-(TETRAHYDRO-PYRAN-2-YL)-ETHYLAMINE METHYL PIPECOLINATE HYDROCHLORIDE 2-CHLOROCYCLOHEXANOL (R)-Piperidine-2-carboxylic acid methyl ester hydrochloride D(+)-Pipecolinic acid N-Dodecanoyl-L-alanine DL-PIPECOLIC ACID HYDROCHLORIDE 1-ETHYL-PIPERIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE SALOR-INT L498580-1EA 2-(dodecylamino)ethanol hydrochloride N-LAUROYLSARCOSINE H-HOMOPRO-OME HCL 1-methyl-piperidine-2-carboxylicacidmethylester GLYCINE N-OCTYL ESTER HYDROCHLORIDE